The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 1886-1895

  Zhao, Bin ^a   Schlesiger, Claudia ^a   Masucci, Maria G ^a   Lindsten, Kristina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Deubiquitinating enzyme (DUB); Nemo like kinase (Nlk); T cell factor 4 (TCF4); Ubiquitin; Ubiquitin specific protease 4 (USP4); Wnt signalling

Indexed keywords

EID: 72949089936     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00682.x     Document Type: Article

References (53)

1. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 2002 82 : 373 428.
2. Sigismund S, Polo S, Di Fiore PP. Signaling through monoubiquitination. Curr Top Microbiol Immunol. 2004 286 : 149 185.
3. Ikeda F, Dikic I. Atypical ubiquitin chains: new molecular signals. 'Protein modifications: beyond the Usual Suspects' review series. EMBO Rep. 2008 9 : 536 542.
4. Nijman SM, Luna-Vargas MP, Velds A, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell. 2005 123 : 773 786.
5. Daviet L, Colland F. Targeting ubiquitin specific proteases for drug discovery. Biochimie. 2007 90 : 270 283.
6. Nicholson B, Marblestone JG, Butt TR, et al. Deubiquitinating enzymes as novel anticancer targets. Future Oncol. 2007 3 : 191 199.
7. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol. 1998 14 : 59 88.
8. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006 127 : 469 480.
9. Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev. 2007 17 : 45 51.
10. Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncol Rep. 2005 14 : 1583 1588.
11. Kohn AD, Moon RT. Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium. 2005 38 : 439 446.
12. Kimelman D, Xu W. Beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene. 2006 25 : 7482 7491.
13. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998 281 : 1509 1512.
14. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999 398 : 422 426.
15. Townsley FM, Cliffe A, Bienz M. Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function. Nat Cell Biol. 2004 6 : 626 633.
16. Mirkovic I, Charish K, Gorski SM, et al. Drosophila Nemo is an essential gene involved in the regulation of programmed cell death. Mech Dev. 2002 119 : 9 20.
17. Verheyen EM, Mirkovic I, MacLean SJ, et al. The tissue polarity gene Nemo carries out multiple roles in patterning during Drosophila development. Mech Dev. 2001 101 : 119 132.
18. Choi KW, Benzer S. Rotation of photoreceptor clusters in the developing Drosophila eye requires the Nemo gene. Cell. 1994 78 : 125 136.
19. Ishitani T, Ninomiya-Tsuji J, Nagai S, et al. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature. 1999 399 : 798 802.
20. Shin TH, Yasuda J, Rocheleau CE, et al. MOM-4, a MAP kinase kinase kinase-related protein, activates WRM-1/LIT-1 kinase to transduce anterior/posterior polarity signals in C. elegans. Mol Cell. 1999 4 : 275 280.
21. Smit L, Baas A, Kuipers J, et al. Wnt activates the Tak1/Nemo-like kinase pathway. J Biol Chem. 2004 279 : 17232 17240.
22. Ishitani T, Ninomiya-Tsuji J, Matsumoto K. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Mol Cell Biol. 2003 23 : 1379 1389.
23. Yamada M, Ohkawara B, Ichimura N, et al. Negative regulation of Wnt signalling by HMG2L1, a novel NLK-binding protein. Genes Cells. 2003 8 : 677 684.
24. Ohkawara B, Shirakabe K, Hyodo-Miura J, et al. Role of the TAK1-NLK-STAT3 pathway in TGF-beta-mediated mesoderm induction. Genes Dev. 2004 18 : 381 386.
25. Kanei-Ishii C, Ninomiya-Tsuji J, Tanikawa J, et al. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev. 2004 18 : 816 829.
26. Yasuda J, Yokoo H, Yamada T, et al. Nemo-like kinase suppresses a wide range of transcription factors, including nuclear factor-kappaB. Cancer Sci. 2004 95 : 52 7.
27. Brummelkamp TR, Nijman SM, Dirac AM, et al. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature. 2003 424 : 797 801.
28. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002 296 : 550 553.
29. Ovaa H, Kessler BM, Rolen U, et al. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. Proc Natl Acad Sci USA. 2004 101 : 2253 2258.
30. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 1997 275 : 1784 1787.
31. Hecht A, Vleminckx K, Stemmler MP, et al. The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J. 2000 19 : 1839 1850.
32. Takemaru KI, Moon RT. The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression. J Cell Biol. 2000 149 : 249 254.
33. Borodovsky A, Ovaa H, Kolli N, et al. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem Biol. 2002 9 : 1149 1159.
34. Soboleva TA, Jans DA, Johnson-Saliba M, et al. Nuclear-cytoplasmic shuttling of the oncogenic mouse UNP/USP4 deubiquitylating enzyme. J Biol Chem. 2005 280 : 745 752.
35. Hood JK, Silver PA. In or out? Regulating nuclear transport. Curr Opin Cell Biol. 1999 11 : 241 247.
36. Yang SH, Sharrocks AD, Whitmarsh AJ. Transcriptional regulation by the MAP kinase signaling cascades. Gene. 2003 320 : 3 21.
37. Zeng YA, Rahnama M, Wang S, et al. Drosophila Nemo antagonizes BMP signaling by phosphorylation of Mad and inhibition of its nuclear accumulation. Development. 2007 134 : 2061 2071.
38. Tran H, Hamada F, Schwarz-Romond T, et al. Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains. Genes Dev. 2008 22 : 528 542.
39. Guillen-Ahlers H. Wnt signaling in renal cancer. Curr Drug Targets. 2008 9 : 591 600.
40. Imreh S, Klein G, Zabarovsky ER. Search for unknown tumor-antagonizing genes. Genes Chromosomes Cancer. 2003 38 : 307 321.
41. Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res. 1997 71 : 27 92.
42. Maitra A, Wistuba II, Washington C, et al. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol. 2001 159 : 119 130.
43. Mohinta S, Wu H, Chaurasia P, et al. Wnt pathway and breast cancer. Front Biosci. 2007 12 : 4020 4033.
44. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene. 2002 21 : 6915 6935.
45. Dehan E, Ben-Dor A, Liao W, et al. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer. 2007.
46. Uematsu K, He B, You L, et al. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene. 2003 22 : 7218 7221.
47. Virmani AK, Rathi A, Sathyanarayana UG, et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res. 2001 7 : 1998 2004.
48. Frederick A, Rolfe M, Chiu MI. The human UNP locus at 3p21.31 encodes two tissue-selective, cytoplasmic isoforms with deubiquitinating activity that have reduced expression in small cell lung carcinoma cell lines. Oncogene. 1998 16 : 153 165. (Pubitemid 28045101)
49. Velazquez-Fernandez D, Laurell C, Geli J, et al. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery. 2005 138 : 1087 1094.
50. Gupta K, Chevrette M, Gray DA. The Unp proto-oncogene encodes a nuclear protein. Oncogene. 1994 9 : 1729 1731.
51. Yamada M, Ohnishi J, Ohkawara B, et al. NARF, an Nemo-like kinase (NLK)-associated ring finger protein regulates the ubiquitylation and degradation of T cell factor/lymphoid enhancer factor (TCF/LEF). J Biol Chem. 2006 281 : 20749 20760.
52. Yamamoto H, Ihara M, Matsuura Y, et al. Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. EMBO J. 2003 22 : 2047 2059.
53. Waltzer L, Bienz M. Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling. Nature. 1998 395 : 521 525.